Home > > > > > Report Detail

Global Molecular Diagnostics in Infectious Disease Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 03-Oct-2022
No. of pages: 113
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Molecular Diagnostics in Infectious Disease Testing companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Molecular Diagnostics in Infectious Disease Testing market. Further, it explains the major drivers and regional dynamics of the global Molecular Diagnostics in Infectious Disease Testing market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Abbott

- BD

- BioMerieux

- Thermo Fisher Scientific

- Roche

- Siemens

- Veridex

- Luminex

- GenMark Diagnostics

- Qiagen

- Genomix Biotech

- BioTheranostics

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Molecular Diagnostics in Infectious Disease Testing Segment by Type

- Polymerase Chain Reaction (PCR)

- Isothermal Nucleic Acid Amplification Technology (INAAT)

- Microarrays

- Next-Generation Sequencing (NGS)

- Hybridization

- Others

Molecular Diagnostics in Infectious Disease Testing Segment by Application

- Hospitals

- Clinics

- Academic Institutes

- Laboratories

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Molecular Diagnostics in Infectious Disease Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Molecular Diagnostics in Infectious Disease Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Molecular Diagnostics in Infectious Disease Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Molecular Diagnostics in Infectious Disease Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Molecular Diagnostics in Infectious Disease Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Molecular Diagnostics in Infectious Disease Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Molecular Diagnostics in Infectious Disease Testing revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott, BD, BioMerieux, Thermo Fisher Scientific, Roche, Siemens, Veridex, Luminex and GenMark Diagnostics, etc.

Global Molecular Diagnostics in Infectious Disease Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.4 Microarrays
1.2.5 Next-Generation Sequencing (NGS)
1.2.6 Hybridization
1.2.7 Others
1.3 Market by Application
1.3.1 Global Molecular Diagnostics in Infectious Disease Testing Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic Institutes
1.3.5 Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size (2017-2028)
2.2 Molecular Diagnostics in Infectious Disease Testing Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2017-2022)
2.4 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Region (2023-2028)
2.5 Global Top Molecular Diagnostics in Infectious Disease Testing Countries Ranking by Market Size
3 Molecular Diagnostics in Infectious Disease Testing Competitive by Company
3.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players
3.1.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2017-2022)
3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players (2017-2022)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Molecular Diagnostics in Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics in Infectious Disease Testing Revenue in 2021
3.5 Global Molecular Diagnostics in Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics in Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Revenue by Type (2017-2022)
4.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Revenue by Type (2023-2028)
5 Global Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Application (2017-2022)
5.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Molecular Diagnostics in Infectious Disease Testing Revenue by Company (2020-2022)
6.2 North America Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2017-2028)
6.3 North America Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2017-2028)
6.4 North America Molecular Diagnostics in Infectious Disease Testing Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Company (2020-2022)
7.2 Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2017-2028)
7.3 Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2017-2028)
7.4 Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Company (2020-2022)
8.2 Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2017-2028)
8.3 Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2017-2028)
8.4 Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Molecular Diagnostics in Infectious Disease Testing Revenue by Company (2020-2022)
9.2 Latin America Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2017-2028)
9.3 Latin America Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2017-2028)
9.4 Latin America Molecular Diagnostics in Infectious Disease Testing Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Company (2020-2022)
10.2 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2017-2028)
10.3 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2017-2028)
10.4 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Products and Services
11.1.4 Abbott Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.1.5 Abbott Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
11.1.6 Abbott Recent Developments
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics in Infectious Disease Testing Products and Services
11.2.4 BD Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.2.5 BD Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
11.2.6 BD Recent Developments
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Products and Services
11.3.4 BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.3.5 BioMerieux Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
11.3.6 BioMerieux Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Products and Services
11.4.4 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.4.5 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
11.4.6 Thermo Fisher Scientific Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Products and Services
11.5.4 Roche Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.5.5 Roche Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
11.5.6 Roche Recent Developments
11.6 Siemens
11.6.1 Siemens Company Details
11.6.2 Siemens Business Overview
11.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Products and Services
11.6.4 Siemens Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.6.5 Siemens Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
11.6.6 Siemens Recent Developments
11.7 Veridex
11.7.1 Veridex Company Details
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Products and Services
11.7.4 Veridex Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.7.5 Veridex Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
11.7.6 Veridex Recent Developments
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Products and Services
11.8.4 Luminex Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.8.5 Luminex Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
11.8.6 Luminex Recent Developments
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Details
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Products and Services
11.9.4 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.9.5 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
11.9.6 GenMark Diagnostics Recent Developments
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Products and Services
11.10.4 Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.10.5 Qiagen Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
11.10.6 Qiagen Recent Developments
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Details
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Products and Services
11.11.4 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.11.5 Genomix Biotech Recent Developments
11.12 BioTheranostics
11.12.1 BioTheranostics Company Details
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Products and Services
11.12.4 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
11.12.5 BioTheranostics Recent Developments
12 Molecular Diagnostics in Infectious Disease Testing Market Dynamics
12.1 Molecular Diagnostics in Infectious Disease Testing Market Trends
12.2 Molecular Diagnostics in Infectious Disease Testing Market Drivers
12.3 Molecular Diagnostics in Infectious Disease Testing Market Challenges
12.4 Molecular Diagnostics in Infectious Disease Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table 4. Key Players of Microarrays
Table 5. Key Players of Next-Generation Sequencing (NGS)
Table 6. Key Players of Hybridization
Table 7. Key Players of Others
Table 8. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Molecular Diagnostics in Infectious Disease Testing Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 10. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Region (2017-2022)
Table 12. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2017-2022) & (US$ Million)
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players (2017-2022)
Table 14. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2021)
Table 15. Ranking of Global Top Molecular Diagnostics in Infectious Disease Testing Companies by Revenue (US$ Million) in 2021
Table 16. Global 5 Largest Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue (CR5 and HHI) & (2017-2022)
Table 17. Key Players Headquarters and Area Served
Table 18. Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
Table 19. Date of Key Manufacturers Enter into Molecular Diagnostics in Infectious Disease Testing Market
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 22. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2017-2022)
Table 23. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 24. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2023-2028)
Table 25. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 26. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2017-2022)
Table 27. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 28. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2023-2028)
Table 29. North America Molecular Diagnostics in Infectious Disease Testing Revenue by Company (2020-2022) & (US$ Million)
Table 30. North America Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2017-2022) & (US$ Million)
Table 31. North America Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2023-2028) & (US$ Million)
Table 32. North America Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2017-2022) & (US$ Million)
Table 33. North America Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2023-2028) & (US$ Million)
Table 34. North America Molecular Diagnostics in Infectious Disease Testing Revenue by Country (2017-2022) & (US$ Million)
Table 35. North America Molecular Diagnostics in Infectious Disease Testing Revenue by Country (2023-2028) & (US$ Million)
Table 36. Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Company (2020-2022) & (US$ Million)
Table 37. Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2017-2022) & (US$ Million)
Table 38. Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2023-2028) & (US$ Million)
Table 39. Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2017-2022) & (US$ Million)
Table 40. Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2023-2028) & (US$ Million)
Table 41. Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Country (2017-2022) & (US$ Million)
Table 42. Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Company (2020-2022) & (US$ Million)
Table 44. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Region (2023-2028) & (US$ Million)
Table 50. Latin America Molecular Diagnostics in Infectious Disease Testing Revenue by Company (2020-2022) & (US$ Million)
Table 51. Latin America Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2017-2022) & (US$ Million)
Table 52. Latin America Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2023-2028) & (US$ Million)
Table 53. Latin America Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2017-2022) & (US$ Million)
Table 54. Latin America Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2023-2028) & (US$ Million)
Table 55. Latin America Molecular Diagnostics in Infectious Disease Testing Revenue by Country (2017-2022) & (US$ Million)
Table 56. Latin America Molecular Diagnostics in Infectious Disease Testing Revenue by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Company (2020-2022) & (US$ Million)
Table 58. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Country (2023-2028) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Molecular Diagnostics in Infectious Disease Testing Product and Services
Table 67. Abbott Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 68. Abbott Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 69. Abbott Recent Developments
Table 70. BD Company Details
Table 71. BD Business Overview
Table 72. BD Molecular Diagnostics in Infectious Disease Testing Product and Services
Table 73. BD Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 74. BD Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 75. BD Recent Developments
Table 76. BioMerieux Company Details
Table 77. BioMerieux Business Overview
Table 78. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product and Services
Table 79. BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 80. BioMerieux Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 81. BioMerieux Recent Developments
Table 82. Thermo Fisher Scientific Company Details
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product and Services
Table 85. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 86. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 87. Thermo Fisher Scientific Recent Developments
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Molecular Diagnostics in Infectious Disease Testing Product and Services
Table 91. Roche Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 92. Roche Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 93. Roche Recent Developments
Table 94. Siemens Company Details
Table 95. Siemens Business Overview
Table 96. Siemens Molecular Diagnostics in Infectious Disease Testing Product and Services
Table 97. Siemens Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 98. Siemens Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 99. Siemens Recent Developments
Table 100. Veridex Company Details
Table 101. Veridex Business Overview
Table 102. Veridex Molecular Diagnostics in Infectious Disease Testing Product and Services
Table 103. Veridex Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 104. Veridex Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 105. Veridex Recent Developments
Table 106. Luminex Company Details
Table 107. Luminex Business Overview
Table 108. Luminex Molecular Diagnostics in Infectious Disease Testing Product and Services
Table 109. Luminex Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 110. Luminex Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 111. Luminex Recent Developments
Table 112. GenMark Diagnostics Company Details
Table 113. GenMark Diagnostics Business Overview
Table 114. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product and Services
Table 115. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 116. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 117. GenMark Diagnostics Recent Developments
Table 118. Qiagen Company Details
Table 119. Qiagen Business Overview
Table 120. Qiagen Molecular Diagnostics in Infectious Disease Testing Product and Services
Table 121. Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 122. Qiagen Molecular Diagnostics in Infectious Disease Testing SWOT Analysis
Table 123. Qiagen Recent Developments
Table 124. Genomix Biotech Company Details
Table 125. Genomix Biotech Business Overview
Table 126. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product and Services
Table 127. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 128. Genomix Biotech Recent Developments
Table 129. BioTheranostics Company Details
Table 130. BioTheranostics Business Overview
Table 131. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product and Services
Table 132. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 133. BioTheranostics Recent Developments
Table 134. Molecular Diagnostics in Infectious Disease Testing Market Trends
Table 135. Molecular Diagnostics in Infectious Disease Testing Market Drivers
Table 136. Molecular Diagnostics in Infectious Disease Testing Market Challenges
Table 137. Molecular Diagnostics in Infectious Disease Testing Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Type: 2021 VS 2028
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Isothermal Nucleic Acid Amplification Technology (INAAT) Features
Figure 4. Microarrays Features
Figure 5. Next-Generation Sequencing (NGS) Features
Figure 6. Hybridization Features
Figure 7. Others Features
Figure 8. Global Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Application: 2021 VS 2028
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Academic Institutes Case Studies
Figure 12. Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Molecular Diagnostics in Infectious Disease Testing Report Years Considered
Figure 15. Global Molecular Diagnostics in Infectious Disease Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Molecular Diagnostics in Infectious Disease Testing Market Size 2017-2028 (US$ Million)
Figure 17. Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Region: 2021 VS 2028
Figure 18. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Region in 2017 VS 2022
Figure 19. Global Top 10 Molecular Diagnostics in Infectious Disease Testing Countries Ranking by Market Size (US$ Million) in 2021
Figure 20. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players in 2021
Figure 21. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2021)
Figure 22. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2021
Figure 23. North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Company in 2021
Figure 24. North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2017-2028)
Figure 25. North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2017-2028)
Figure 26. North America Molecular Diagnostics in Infectious Disease Testing Revenue Share by Country (2017-2028)
Figure 27. U.S. Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 28. Canada Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 29. Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Company in 2021
Figure 30. Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2017-2028)
Figure 31. Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2017-2028)
Figure 32. Europe Molecular Diagnostics in Infectious Disease Testing Revenue Share by Country (2017-2028)
Figure 33. Germany Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 34. France Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 35. U.K. Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 36. Italy Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 37. Russia Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 38. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Company in 2021
Figure 39. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2017-2028)
Figure 40. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2017-2028)
Figure 41. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Share by Region (2017-2028)
Figure 42. China Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 43. Japan Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 44. South Korea Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 45. India Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 46. Australia Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 47. Taiwan Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 48. Indonesia Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 49. Thailand Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 50. Malaysia Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 51. Philippines Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 52. Vietnam Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 53. Latin America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Company in 2021
Figure 54. Latin America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2017-2028)
Figure 55. Latin America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2017-2028)
Figure 56. Latin America Molecular Diagnostics in Infectious Disease Testing Revenue Share by Country (2017-2028)
Figure 57. Mexico Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 58. Brazil Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Million)
Figure 59. Argentina Molecular Diagnostics in Infectious Disease Testing Revenue (2017-2028) & (US$ Mi
  • 2023 World Molecular Diagnostics Market in 92 Countries: 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
    Published: 23-Jan-2023        Price: US 24500 Onwards        Pages: 0
    This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for major tests. Geographic Regions and Countries Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indones......
  • 2023 Asia-Pacific Molecular Diagnostics Market in 18 Countries: 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
    Published: 23-Jan-2023        Price: US 9500 Onwards        Pages: 0
    This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for major tests. Country Analyses Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pa......
  • 2023 Europe Molecular Diagnostics Market in 38 Countries: 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
    Published: 23-Jan-2023        Price: US 14500 Onwards        Pages: 0
    This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for major tests. Country Analyses Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Fin......
  • 2023 Latin America Molecular Diagnostics Market in 22 Countries: 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
    Published: 23-Jan-2023        Price: US 9500 Onwards        Pages: 0
    This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for major tests. Country Analyses Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salva......
  • 2023 Middle East Molecular Diagnostics Market in 11 Countries: 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
    Published: 23-Jan-2023        Price: US 7500 Onwards        Pages: 0
    This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for major tests. Country Analyses Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirate......
  • 2023 North America Molecular Diagnostics Market in the US, Canada, Mexico--2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
    Published: 23-Jan-2023        Price: US 7500 Onwards        Pages: 0
    This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for major tests. Country Analyses Canada, Mexico, USAThe companies profiled in the report include:Abbott Agilent ......
  • 2023 Global Molecular Diagnostics Market in the US, Europe, Japan--2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
    Published: 23-Jan-2023        Price: US 14500 Onwards        Pages: 0
    This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for major tests. Countries France, Germany, Italy, Japan, Spain, UK, USThe companies profiled in the report include:Abbott ......
  • 2023 Europe Molecular Diagnostics Market in France, Germany, Italy, Spain, UK--2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
    Published: 23-Jan-2023        Price: US 14500 Onwards        Pages: 0
    This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for major tests. Countries France, Germany, Italy, Spain, UKThe companies profiled in the report include:Abbott Agilent ......
  • 2023 France Molecular Diagnostics Market: 2022 Supplier Shares, Instrumentation Installed Base and Strategies, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
    Published: 23-Jan-2023        Price: US 1850 Onwards        Pages: 0
    This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for major tests.The companies profiled in the report include:Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs